| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Molecular Angiogenesis Group (L.Z., R.B.), Imperial Cancer Research Fund Laboratories, Institute of Molecular Medicine, and Nuffield Department of Obstetrics and Gynaecology (L.Z., I.Z.M., M.C.P.R.), University of Oxford, John Radcliffe Hospital, Oxford OX3 9DU, United Kingdom
Address all correspondence and requests for reprints to: Roy Bicknell, Molecular Angiogenesis Group, Imperial Cancer Research Fund Laboratories, Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DU, United Kingdom. E-mail: bicknelr{at}icrf.icnet.uk
The angiogenic enzyme platelet-derived endothelial cell growth
factor/thymidine phosphorylase (PD-ECGF/TP) was strongly expressed in
the endometrial glands in the luteal and menstrual, but not the
proliferative, phases of the cycle. The converse was seen in the
stroma, where expression was strong in the proliferative, but not the
luteal or menstrual, phases. Inflammatory cytokines induced PD-ECGF/TP
expression in primary cultures of human normal endometrial epithelial
(NEE) and normal endometrial stromal cells. The profile of cytokine
induction of PD-ECGF/TP was cell dependent. Thus, in NEE cells,
PD-ECGF/TP expression was strongly induced by the combination tumor
necrosis factor-
and interferon-
. In contrast, in normal
endometrial stromal cells, interferon-
gave, by far, the strongest
induction of PD-ECGF/TP. Expression of the enzyme was not regulated by
ovarian hormones alone. Although treatment of NEE cells with a
physiological concentration of progesterone (5 x
10-8 M) or transforming growth
factor-ß1 (10 ng/ml) alone had no effect on PD-ECGF/TP
expression, when delivered together at the same dose they induced a
48-fold increase in expression. This expression correlates with cyclic
changes in progesterone and transforming growth factor-ß1
levels in the uterus.
This article has been cited by other articles:
![]() |
L.L. Nikitenko, I.Z. MacKenzie, M.C.P. Rees, and R. Bicknell Adrenomedullin is an autocrine regulator of endothelial growth in human endometrium Mol. Hum. Reprod., September 1, 2000; 6(9): 811 - 819. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Sivridis, A. Giatromanolaki, M. I Koukourakis, R. Bicknell, A. L Harris, and K. C Gatter Thymidine phosphorylase expression in normal and hyperplastic endometrium J. Clin. Pathol., September 1, 2000; 53(9): 704 - 708. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hague, L. Zhang, M. K. Oehler, S. Manek, I. Z. MacKenzie, R. Bicknell, and M. C. P. Rees Expression of the Hypoxically Regulated Angiogenic Factor Adrenomedullin Correlates with Uterine Leiomyoma Vascular Density Clin. Cancer Res., July 1, 2000; 6(7): 2808 - 2814. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |